Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $2.22 billion. The enterprise value is $2.13 billion.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 28.69 million shares outstanding. The number of shares has increased by 23.05% in one year.
| Current Share Class | 28.69M |
| Shares Outstanding | 28.69M |
| Shares Change (YoY) | +23.05% |
| Shares Change (QoQ) | +7.13% |
| Owned by Insiders (%) | 0.62% |
| Owned by Institutions (%) | 66.13% |
| Float | 26.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.25 |
| Forward PS | 52.60 |
| PB Ratio | 17.58 |
| P/TBV Ratio | 24.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 38.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 1.66.
| Current Ratio | 4.97 |
| Quick Ratio | 4.62 |
| Debt / Equity | 1.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.99 |
Financial Efficiency
Return on equity (ROE) is -217.94% and return on invested capital (ROIC) is -33.10%.
| Return on Equity (ROE) | -217.94% |
| Return on Assets (ROA) | -27.98% |
| Return on Invested Capital (ROIC) | -33.10% |
| Return on Capital Employed (ROCE) | -57.64% |
| Weighted Average Cost of Capital (WACC) | 10.92% |
| Revenue Per Employee | $876,698 |
| Profits Per Employee | -$2.60M |
| Employee Count | 63 |
| Asset Turnover | 0.19 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -138,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +911.88% in the last 52 weeks. The beta is 1.18, so NKTR's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +911.88% |
| 50-Day Moving Average | 66.19 |
| 200-Day Moving Average | 49.09 |
| Relative Strength Index (RSI) | 59.90 |
| Average Volume (20 Days) | 803,953 |
Short Selling Information
The latest short interest is 3.66 million, so 12.77% of the outstanding shares have been sold short.
| Short Interest | 3.66M |
| Short Previous Month | 3.67M |
| Short % of Shares Out | 12.77% |
| Short % of Float | 13.59% |
| Short Ratio (days to cover) | 3.55 |
Income Statement
In the last 12 months, NKTR had revenue of $55.23 million and -$164.08 million in losses. Loss per share was -$9.73.
| Revenue | 55.23M |
| Gross Profit | 55.23M |
| Operating Income | -130.77M |
| Pretax Income | -164.21M |
| Net Income | -164.08M |
| EBITDA | -129.75M |
| EBIT | -130.77M |
| Loss Per Share | -$9.73 |
Full Income StatementBalance Sheet
The company has $245.75 million in cash and $148.91 million in debt, with a net cash position of $96.84 million or $3.38 per share.
| Cash & Cash Equivalents | 245.75M |
| Total Debt | 148.91M |
| Net Cash | 96.84M |
| Net Cash Per Share | $3.38 |
| Equity (Book Value) | 89.83M |
| Book Value Per Share | 4.41 |
| Working Capital | 212.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$208.51 million and capital expenditures -$868,000, giving a free cash flow of -$209.38 million.
| Operating Cash Flow | -208.51M |
| Capital Expenditures | -868,000 |
| Depreciation & Amortization | 1.03M |
| Net Borrowing | 180.85M |
| Free Cash Flow | -209.38M |
| FCF Per Share | -$7.30 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -236.77% and -297.07%.
| Gross Margin | 100.00% |
| Operating Margin | -236.77% |
| Pretax Margin | -297.32% |
| Profit Margin | -297.07% |
| EBITDA Margin | -234.91% |
| EBIT Margin | -236.77% |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.05% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.38% |
| FCF Yield | -9.42% |
Analyst Forecast
The average price target for NKTR is $130.00, which is 67.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $130.00 |
| Price Target Difference | 67.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 40.03% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
NKTR has an Altman Z-Score of -17.59 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.59 |
| Piotroski F-Score | 3 |
